Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Brink

Showing results (1-10 of 110) with videos related to

Pageof 11
Sort By:
Acta Oncologica (Stockholm, Sweden)|January 18, 2012
Does VMAT for treatment of NSCLC patients increase the risk of pneumonitis compared to IMRT ? - a planning studyAnders Bertelsen, Olfred Hansen, Carsten Brink
Medical Physics|October 12, 2007
Sensitivity of NTCP parameter values against a change of dose calculation algorithmCarsten Brink, Martin Berg, Morten Nielsen
Medical Physics|September 21, 2011
Validation of a new control system for Elekta accelerators facilitating continuously variable dose rateAnders Bertelsen, Ebbe L Lorenzen, Carsten Brink
Acta Oncologica (Stockholm, Sweden)|September 17, 2014
Automatic segmentation of the heart in radiotherapy for breast cancerEbbe L Lorenzen, Marianne Ewertz, Carsten Brink
Acta Oncologica (Stockholm, Sweden)|December 19, 2012
Radiopaque marker motion during pre-treatment CBCT as a predictor of intra-fractional prostate movementUffe Bernchou, Søren N Agergaard, Carsten Brink
Acta Oncologica (Stockholm, Sweden)|May 4, 2017
Magnetic resonance only workflow and validation of dose calculations for radiotherapy of prostate cancerRasmus L Christiansen, Henrik R Jensen, Carsten Brink
Acta Oncologica (Stockholm, Sweden)|October 8, 2014
Age dependent prognosis in concurrent chemo-radiation of locally advanced NSCLCOlfred Hansen, Tine Schytte, Morten Nielsen, et al.
Acta Oncologica (Stockholm, Sweden)|May 1, 2013
Inhomogeneous dose escalation increases expected local control for NSCLC patients with lymph node involvement without increased mean lung doseTine B Nielsen, Olfred Hansen, Tine Schytte, et al.
Acta Oncologica (Stockholm, Sweden)|September 14, 2013
Four-dimensional dose evaluation of inhomogeneous dose distributions planned for non-small cell lung cancer patients with lymph node involvementTine B Nielsen, Olfred Hansen, Tine Schytte, et al.
Acta Oncologica (Stockholm, Sweden)|December 28, 2013
Pattern of loco-regional failure after definitive radiotherapy for non-small cell lung cancerTine Schytte, Tine Bjørn Nielsen, Carsten Brink, et al.
Pageof 11

Showing results (1-10 of 110) with videos related to

Sort By:
Pageof 11
Acta Oncologica (Stockholm, Sweden)|January 18, 2012
Does VMAT for treatment of NSCLC patients increase the risk of pneumonitis compared to IMRT ? - a planning studyAnders Bertelsen, Olfred Hansen, Carsten Brink
Medical Physics|October 12, 2007
Sensitivity of NTCP parameter values against a change of dose calculation algorithmCarsten Brink, Martin Berg, Morten Nielsen
Medical Physics|September 21, 2011
Validation of a new control system for Elekta accelerators facilitating continuously variable dose rateAnders Bertelsen, Ebbe L Lorenzen, Carsten Brink
Acta Oncologica (Stockholm, Sweden)|September 17, 2014
Automatic segmentation of the heart in radiotherapy for breast cancerEbbe L Lorenzen, Marianne Ewertz, Carsten Brink
Acta Oncologica (Stockholm, Sweden)|December 19, 2012
Radiopaque marker motion during pre-treatment CBCT as a predictor of intra-fractional prostate movementUffe Bernchou, Søren N Agergaard, Carsten Brink
Acta Oncologica (Stockholm, Sweden)|May 4, 2017
Magnetic resonance only workflow and validation of dose calculations for radiotherapy of prostate cancerRasmus L Christiansen, Henrik R Jensen, Carsten Brink
Acta Oncologica (Stockholm, Sweden)|October 8, 2014
Age dependent prognosis in concurrent chemo-radiation of locally advanced NSCLCOlfred Hansen, Tine Schytte, Morten Nielsen, et al.
Acta Oncologica (Stockholm, Sweden)|May 1, 2013
Inhomogeneous dose escalation increases expected local control for NSCLC patients with lymph node involvement without increased mean lung doseTine B Nielsen, Olfred Hansen, Tine Schytte, et al.
Acta Oncologica (Stockholm, Sweden)|September 14, 2013
Four-dimensional dose evaluation of inhomogeneous dose distributions planned for non-small cell lung cancer patients with lymph node involvementTine B Nielsen, Olfred Hansen, Tine Schytte, et al.
Acta Oncologica (Stockholm, Sweden)|December 28, 2013
Pattern of loco-regional failure after definitive radiotherapy for non-small cell lung cancerTine Schytte, Tine Bjørn Nielsen, Carsten Brink, et al.
Pageof 11